RxDoctor Payments Data

Steven Eyre, MD

Procedural Dermatology · Orem, UTNPI 1174520597

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $436 and has fallen 67.9% since, to $140 in 2025.

$1,390in general payments, 2019–2025

Across 52 payments — averaging $26.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$274
  • Amgen$191
  • Galderma Laboratories, L.p.$158
  • Dermavant Sciences, Inc.$126
  • Boehringer Ingelheim$110
  • Pfizer$62
  • plus $469 from 10 others

What the payments were for

  • Food & beverage$1,390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few procedural dermatology providers in Utahto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$163,875
Medicare patients
457
Services billed
3,173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate89$3,243
Imiquimod55$1,393
Ketoconazole75$1,353
Tacrolimus12$1,283
Triamcinolone Acetonide73$1,088
ValacyclovirValacyclovir Hcl33$967
Desonide21$951
Dutasteride34$737
Metronidazole19$715
Fluocinonide19$706
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc31$541
Mupirocin60$486
Minoxidil32$458
Spironolactone12$457
Minocycline Hcl16$410

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Orem

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →